McKesson EBITDA Margin 2010-2025 | MCK

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for McKesson (MCK) over the last 10 years. The current EBITDA margin for McKesson as of March 31, 2025 is .
McKesson EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $359.05B $5.06B 1.41%
2024-12-31 $344.58B $4.69B 1.36%
2024-09-30 $330.19B $4.12B 1.25%
2024-06-30 $313.75B $4.48B 1.43%
2024-03-31 $308.95B $4.54B 1.47%
2023-12-31 $301.51B $4.31B 1.43%
2023-09-30 $291.10B $4.90B 1.68%
2023-06-30 $284.04B $5.06B 1.78%
2023-03-31 $276.71B $4.99B 1.80%
2022-12-31 $273.90B $4.64B 1.70%
2022-09-30 $272.03B $3.74B 1.37%
2022-06-30 $268.45B $3.20B 1.19%
2022-03-31 $263.97B $2.80B 1.06%
2021-12-31 $257.01B $3.24B 1.26%
2021-09-30 $250.99B $-4.25B -1.69%
2021-06-30 $245.22B $-4.02B -1.64%
2021-03-31 $238.23B $-3.91B -1.64%
2020-12-31 $237.62B $-4.02B -1.69%
2020-09-30 $234.19B $3.67B 1.57%
2020-06-30 $231.00B $3.58B 1.55%
2020-03-31 $231.05B $3.55B 1.54%
2019-12-31 $224.95B $3.50B 1.56%
2019-09-30 $221.98B $3.79B 1.71%
2019-06-30 $217.44B $3.85B 1.77%
2019-03-31 $214.32B $3.91B 1.83%
2018-12-31 $213.52B $3.83B 1.79%
2018-09-30 $210.93B $3.91B 1.86%
2018-06-30 $209.91B $4.00B 1.90%
2018-03-31 $208.36B $3.93B 1.89%
2017-12-31 $205.44B $7.93B 3.86%
2017-09-30 $201.96B $7.90B 3.91%
2017-06-30 $199.85B $7.97B 3.99%
2017-03-31 $198.53B $8.32B 4.19%
2016-12-31 $196.50B $4.30B 2.19%
2016-09-30 $194.27B $4.40B 2.27%
2016-06-30 $193.07B $4.49B 2.33%
2016-03-31 $190.88B $4.44B 2.32%
2015-12-31 $189.13B $4.65B 2.46%
2015-09-30 $187.72B $4.56B 2.43%
2015-06-30 $183.12B $4.43B 2.42%
2015-03-31 $179.05B $4.23B 2.36%
2014-12-31 $171.95B $3.90B 2.27%
2014-09-30 $159.80B $3.51B 2.19%
2014-06-30 $148.63B $3.32B 2.23%
2014-03-31 $137.39B $3.17B 2.31%
2013-12-31 $130.20B $3.19B 2.45%
2013-09-30 $126.97B $3.17B 2.49%
2013-06-30 $123.74B $3.04B 2.46%
2013-03-31 $122.20B $2.93B 2.40%
2012-12-31 $122.84B $2.83B 2.30%
2012-09-30 $122.58B $2.83B 2.31%
2012-06-30 $123.04B $2.71B 2.20%
2012-03-31 $122.32B $2.62B 2.14%
2011-12-31 $119.89B $2.62B 2.18%
2011-09-30 $117.30B $2.41B 2.05%
2011-06-30 $114.61B $2.33B 2.03%
2011-03-31 $112.08B $2.32B 2.07%
2010-12-31 $109.87B $2.25B 2.05%
2010-09-30 $109.90B $2.46B 2.24%
2010-06-30 $109.50B $2.51B 2.29%
2010-03-31 $108.70B $2.48B 2.28%
2009-12-31 $108.28B $2.39B 2.21%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $89.440B $359.051B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $48.912B 12.11
Cardinal Health (CAH) United States $37.110B 19.43
Labcorp (LH) United States $20.968B 17.01
Straumann Holding AG (SAUHY) Switzerland $20.602B 0.00
West Pharmaceutical Services (WST) United States $15.134B 31.72
Cooper (COO) United States $13.381B 17.25
Align Technology (ALGN) United States $12.986B 25.78
Henry Schein (HSIC) United States $8.590B 14.73
Merit Medical Systems (MMSI) United States $5.591B 27.03
DENTSPLY SIRONA (XRAY) United States $3.167B 9.46
CONMED (CNMD) United States $1.761B 13.17
STAAR Surgical (STAA) United States $0.849B 0.00
Lifevantage (LFVN) United States $0.162B 16.69
Pro-Dex (PDEX) United States $0.140B 15.28